These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24053790)

  • 1. Assessing the anatomical characteristics of renal masses has a limited effect on the prediction of pathological outcomes in solid, enhancing, small renal masses: results using the PADUA classification system.
    Shin TY; Kim J; Koo KC; Lim SK; Kim DW; Kang MW; Rha KH; Choi YD; Ham WS
    BJU Int; 2014 May; 113(5):754-61. PubMed ID: 24053790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
    Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
    J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solitary solid renal mass: can we predict malignancy?
    Violette P; Abourbih S; Szymanski KM; Tanguay S; Aprikian A; Matthews K; Brimo F; Kassouf W
    BJU Int; 2012 Dec; 110(11 Pt B):E548-52. PubMed ID: 22612453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score.
    Kutikov A; Smaldone MC; Egleston BL; Manley BJ; Canter DJ; Simhan J; Boorjian SA; Viterbo R; Chen DY; Greenberg RE; Uzzo RG
    Eur Urol; 2011 Aug; 60(2):241-8. PubMed ID: 21458155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of the RENAL nephrometry score nomogram for predicting high-grade renal cell carcinoma in solid, enhancing, and small renal masses.
    Koo KC; Yoo H; Shin TY; Kim J; Choi YD; Rha KH; Ham WS
    World J Urol; 2014 Feb; 32(1):249-55. PubMed ID: 24013182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of anatomic and morphologic nomogram to predict malignant and high-grade disease in a cohort of patients with small renal masses.
    Bagrodia A; Harrow B; Liu ZW; Olweny EO; Faddegon S; Yin G; Tan YK; Han WK; Lotan Y; Margulis V; Cadeddu JA
    Urol Oncol; 2014 Jan; 32(1):37.e17-23. PubMed ID: 23628308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A classification tree for the prediction of benign versus malignant disease in patients with small renal masses.
    Rendon RA; Mason RJ; Kirkland S; Lawen JG; Abdolell M
    Can J Urol; 2014 Aug; 21(4):7379-84. PubMed ID: 25171283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of locally advanced and metastatic disease in patients with small renal masses.
    Kates M; Korets R; Sadeghi N; Pierorazio PM; McKiernan JM
    BJU Int; 2012 May; 109(10):1463-7. PubMed ID: 21933329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk Stratification Algorithm Based on Biopsy and Mass Size for Assigning Surveillance versus Treatment of Renal Tumors.
    Osawa T; Hafez KS; Miller DC; Montgomery JS; Morgan TM; Palapattu GS; Weizer AZ; Caoili EM; Ellis JH; Kunju LP; Wolf JS
    J Urol; 2016 Mar; 195(3):574-80. PubMed ID: 26523883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours.
    Kim EH; Tanagho YS; Bhayani SB; Saad NE; Benway BM; Figenshau RS
    BJU Int; 2013 May; 111(6):872-9. PubMed ID: 23145500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is surveillance of small renal masses safe in the elderly?
    O'Malley RL; Godoy G; Phillips CK; Taneja SS
    BJU Int; 2010 Apr; 105(8):1098-101. PubMed ID: 19849693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation and external validation of Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) score for predicting complications in 74 consecutive partial nephrectomies.
    Tyritzis SI; Papadoukakis S; Katafigiotis I; Adamakis I; Anastasiou I; Stravodimos KG; Alamanis C; Mitropoulos D; Constantinides CA
    BJU Int; 2012 Jun; 109(12):1813-8. PubMed ID: 21981696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of perinephric fat surface area and Mayo Adhesive Probability score in predicting malignancy in T1 renal masses.
    Bernstein AP; Fram EB; Sankin A; Kovac E; Srivastava A; DiVito J; Stern JM
    Urol Oncol; 2018 Nov; 36(11):499.e17-499.e22. PubMed ID: 30166240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of renal mass aggressiveness using clinical and radiographic features: a global, multicentre prospective study.
    Golan S; Eggener S; Subotic S; Barret E; Cormio L; Naito S; Tefekli A; Pilar Laguna Pes M
    BJU Int; 2016 Jun; 117(6):914-22. PubMed ID: 26389787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis.
    Ball MW; Gorin MA; Bhayani SB; Rogers CG; Stifelman MD; Kaouk JH; Zargar H; Marshall S; Larson JA; Rahbar HM; Trock BJ; Pierorazio PM; Allaf ME
    Urol Oncol; 2015 Mar; 33(3):112.e9-14. PubMed ID: 25499258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of trifecta outcomes in laparoscopic partial nephrectomy for clinical T1a renal masses.
    Osaka K; Makiyama K; Nakaigawa N; Yao M
    Int J Urol; 2015 Nov; 22(11):1000-5. PubMed ID: 26251228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma.
    Hsiao W; Herrel LA; Yu C; Kattan MW; Canter DJ; Carthon BC; Ogan K; Master VA
    Int J Urol; 2015 Mar; 22(3):264-70. PubMed ID: 25428139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of tumour size in patients after tumour nephrectomy for localised renal cell carcinoma.
    Steiner T; Knels R; Schubert J
    Eur Urol; 2004 Sep; 46(3):327-30. PubMed ID: 15306102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing malignant and benign renal masses with composite models and nomograms: A systematic review and meta-analysis of clinically localized renal masses suspicious for malignancy.
    Pierorazio PM; Patel HD; Johnson MH; Sozio SM; Sharma R; Iyoha E; Bass EB; Allaf ME
    Cancer; 2016 Nov; 122(21):3267-3276. PubMed ID: 27508947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Trifecta and Pentafecta Outcomes between T1a and T1b Renal Masses following Robot-Assisted Partial Nephrectomy (RAPN) with Minimum One Year Follow Up: Can RAPN for T1b Renal Masses Be Feasible?
    Kim DK; Kim LH; Raheem AA; Shin TY; Alabdulaali I; Yoon YE; Han WK; Rha KH
    PLoS One; 2016; 11(3):e0151738. PubMed ID: 26987069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.